OptimizeRx Q4 results ‘at odds with muted’ outlook, says Roth MKM
Roth MKM reiterates a Buy rating on OptimizeRx (OPRX) with a $16 price target following the Q4 report. The company reported “strong” results ...
Roth MKM Reaffirms Their Buy Rating on Zevra Therapeutics (ZVRA)
In a report released today, Jonathan Aschoff from Roth MKM maintained a Buy rating on Zevra Therapeutics (ZVRA – Research Report), with a price ...
New Found Gold (NYSE:NFGC) Given New $5.00 Price Target at Roth Mkm
New Found Gold (NYSE:NFGC – Get Free Report) had its target price decreased by equities researchers at Roth Mkm from $9.00 to $5.00 in a note issued to investors on Monday,Benzinga reports. The ...
Hosted on MSN1mon
Roth/MKM raises PLBY Group stock rating to Buy, targets $3
On Friday, Roth/MKM analysts reinstated coverage on PLBY Group, Inc. (NASDAQ: PLBY) with a Buy rating and set a price target of $3.00, representing significant upside from the current price of $1.66.
3LUNR : A Closer Look at Intuitive Machines's Options Market Dynamics
Today, Benzinga's options scanner identified 8 options transactions for Intuitive Machines. This is an unusual occurrence.
GeoVax to Present at the 37th Annual Roth Conference
GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and ...
Arbe Robotics price target lowered to $3 from $5 at Roth MKM
Roth MKM analyst Suji Desilva lowered the firm’s price target on Arbe Robotics (ARBE) to $3 from $5 and keeps a Buy rating on ...
Analysts Highlight Credo Hyperscaler Partnerships With Amazon, Microsoft, xAI Amid AI Boom
Credo Technology Group (NASDAQ:CRDO) issued its third-quarter earnings report on Tuesday. It reported quarterly earnings of ...